Patent · US Active

Modified kappa light chain-binding polypeptides

US10208091B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Assignee

GE Healthcare BioProcess R&D AB · SE

Inventors

Gustav Rodrigo · Uppsala, SE
Mats Ander · Uppsala, SE
Tomas Bjorkman · Uppsala, SE

Key dates

Filing date	Dec 11, 2015
Grant date	Feb 19, 2019
Priority date	—
Expiry date	Dec 11, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/02
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A kappa light chain-binding polypeptide comprising or consisting essentially of one or more binding domains of Peptostreptococcus Protein L, each of said domains being selected from the group consisting of domain 2, domain 3 and domain 4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.